Mitsubishi UFJ Asset Management
MRVI icon

Mitsubishi UFJ Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$184K Sell
64,860
-1,603
-2% -$5.43K ﹤0.01% 992
2025
Q4 		$226K Buy
+66,463
New +$224K ﹤0.01% 1000
2025
Q2 		– Sell
-57,311
Closed -$127K – 1635
2025
Q1 		$127K Buy
57,311
+4,803
+9% +$19K ﹤0.01% 1003
2024
Q4 		$298K Buy
52,508
+28,480
+119% +$183K ﹤0.01% 930
2024
Q3 		$200K Sell
24,028
-2,266
-9% -$19.6K ﹤0.01% 965
2024
Q2 		$188K Sell
26,294
-21,373
-45% -$185K ﹤0.01% 965
2024
Q1 		$413K Sell
47,667
-2,183
-4% -$14.8K ﹤0.01% 892
2023
Q4 		$316K Buy
49,850
+29,231
+142% +$189K ﹤0.01% 969
2023
Q3 		$206K Buy
20,619
+1,170
+6% +$12.8K ﹤0.01% 1020
2023
Q2 		$242K Buy
19,449
+815
+4% +$11K ﹤0.01% 1020
2023
Q1 		$261K Buy
18,634
+1,264
+7% +$18.2K ﹤0.01% 994
2022
Q4 		$238K Buy
17,370
+9,765
+128% +$154K ﹤0.01% 1005
2022
Q3 		$194K Hold
7,605
– – ﹤0.01% 1026
2022
Q2 		$216K Sell
7,605
-861
-10% -$27.3K ﹤0.01% 1037
2022
Q1 		$299K Buy
8,466
+914
+12% +$30.6K ﹤0.01% 1000
2021
Q4 		$300K Buy
7,552
+1,761
+30% +$71.3K ﹤0.01% 1010
2021
Q3 		$284K Sell
5,791
-50
-0.9% -$2.44K ﹤0.01% 1016
2021
Q2 		$244K Buy
+5,841
New +$226K ﹤0.01% 1069

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mitsubishi UFJ Asset Management's MRVI Position: Q1 2026 in Review

Mitsubishi UFJ Asset Management reduced its Maravai LifeSciences (MRVI) stake by 2.4% in Q1 2026, selling an estimated $5.43K and leaving 64,860 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #992.

Mitsubishi UFJ Asset Management first reported a position in MRVI in Q2 2021 and has held it in 18 quarters since. The position peaked at $413K in Q1 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Mitsubishi UFJ Asset Management held 64,860 shares of Maravai LifeSciences worth $184K as of Q1 2026.
  • Mitsubishi UFJ Asset Management sold 1,603 Maravai LifeSciences shares in Q1 2026, an estimated $5.43K.
  • Maravai LifeSciences made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q1 2026, its #992 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Maravai LifeSciences in Q2 2021 and has held it in 18 quarters since.
  • Mitsubishi UFJ Asset Management's Maravai LifeSciences position peaked at $413K in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2026, filed 12 May 2026.